ArticleAsian Pacific journal of cancer prevention : APJCP2025
Incidence of Colorectal Cancer in Loei Province, Thailand: Report from a Population-Based Cancer Registry.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundData regarding trends in Colorectal Cancer (CRC) incidence within Loei province are currently unavailable. Additionally, there is a scarcity of information from previous studies examining CRC time trends across Thailand.
objectiveThe purpose of this study was to study the estimate the trend and incidence of CRC in Loei Province.
methodsAn analytical retrospective cohort study was conducted using data from the Loei population-based cancer registry, collected through the Thai cancer-based program of National Cancer Institute of Thailand. A total of 754 patients were diagnosed with CRC (IDC-O-3, C18.0, C18.1, C18.2, C18.3, C18.4, C18.5, C18.6, C18.7, C18.8, C18.9, C1.9, C2.0) in Loei during 2017 - 2022. Age-standardized rates (ASR) were estimated, and their 95% confidence interval were reported. Annual percent change (APC) was calculated to quantify the incidence rate trends using Join-point regression. Both APC and 95% confidence interval were reported.
resultWe found that the overall ASR from 2017 to 2022 for all ages was 13.7 per 100 000 person-years for both sexes. (95% CI; 12.88, 14.56). Male ASR =15.54 per 100,000 person-years (95% CI; 14.70, 16.38). Female ASR = 12.07 per 100,000 person-years (95% CI; 11.23, 12.91). Additionally, the preliminary trends of overall CRC incidence increased between 2017 to 2022 by an APC of 3.72% (APC= 3.72; 95% CI; -6.62, 15.85). The percentage change for males increased by 5.49 % (APC= 5.49; 95% CI; -2.13, 14.26) per year. For females, the annual percentage change increased by 1.91 percent (APC= 1.91; 95% CI; -14.20, 22.53).
conclusionOur preliminary findings show an increasing trend in CRC incidence among both men and women in Loei Province. To gain a more comprehensive understanding and identify clearer patterns, future studies should analyze these trends over extended periods, such as 10 years or more. Evaluating the coverage and completeness of the cancer registry data will also be crucial. This knowledge will provide a foundation for planning effective CRC prevention and control strategies in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.